114

Daily Stock Market Report (Tue 21st April 2026) - CRST, JUP, MPAC, G4M, SYS1, SUS, IGP, CAPD

Good morning!

There has been little change in the macro situation overnight: the FTSE is at 10,600, Brent crude is at $95, and US-Iran talks are set to happen over the next two days.

All the while, 800 vessels remain trapped in the Persian gulf, with the majority of them being oil tankers and other carriers of fuels.


Done for today, thanks for your patience! Spreadsheet accompanying this report: link.


Companies Reporting

Name (Mkt Cap)RNSSummaryOur view (Author)

AstraZeneca (LON:AZN) (£232bn | SR74)

I CAN PhIII interim analysis met primary endpoint

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary endpoint, demonstrating a statistically significant and clinically meaningful reduction of proteinuria.

Rio Tinto (LON:RIO) (£120bn | SR85)

Drilling/Production Report

Q1 copper production +9%, iron ore production +12%, although weather disruption means shipments only rose by 2%. No change to 2026 guidance.

Experian (LON:EXPN) (£26bn | SR44)

Chair appointment

Adam Crozier to be Chair after AGM in July. Currently Chair of BT Group, previously Chair of Whitbread and ASOS.

Associated British Foods (LON:ABF) (£13.3bn | SR73)

Outcome of its review of Group Structure & Interim Results Announcements

Has decided to proceed with a demerger of Primark and Foodco. Both Primark and Foodco to be listed. H1 results: revenue down 2%, adj. operating profit down 18%. Outlook: “Our full year outlook is currently unchanged, with the exception of Sugar where we now expect an adjusted operating loss in 2026.” Continues to expect H2 weighting.

British Land (LON:BLND) (£3.96bn | SR54)

Q4 Trading Update

FY26 Underlying EPS of 28.9p, ahead of guidance. Also upgrading FY27 Underlying EPS guidance to at least 30.5p (previously 30.2p).

Integrafin Holdings (LON:IHP) (£1.13bn | SR51)

Q2 Trading Update

Total Group revenue is expected to be up 11% at c.£85.8m for H1 FY26. No change to cost guidance given in December 2025.

Jupiter Fund Management (LON:JUP) (£807m | SR95)

Trading Update and Notice of Results

AUM +27% since year-end driven by CCLA acquisition and positive net inflows (£1.5bn).

GREEN = (Graham)
I respect the momentum at work here, and will stay positive. There are a few fund management businesses on my GREEN list - and Jupiter is one of them. Ever since Matthew Beesley was hired as CEO in 2022, I thought his plans were remarkably logical - primarily around cost control and simplification in a tough environment. Patient shareholders have been rewarded with positive net inflows, a cheap acquisition significantly boosting AUM, and a recovery in the share price.

XPS Pensions (LON:XPS) (£659m | SR52)

Post-Close Trading Update

Strong revenue growth coupled with ongoing disciplined cost management and delivery of operating efficiencies means the Board is confident of achieving full year results in line with expectations.

THG (LON:THG) (£654m | SR40)

Trading Statement

Revenue +7% at constant currency. Full year guidance reiterated.

Griffin Mining (LON:GFM) (£512m | SR53)

Zone II Production Commenced

“Extremely pleased” to announce that the first production blast in Zone II was completed yesterday.

Ibstock (LON:IBST) (£423m | SR31)

Appointment of Chief Financial Officer

The new CFO joins from Mpac where he has been CFO since 2018. Expected to start in August.

VAALCO Energy (LON:EGY) (£412m | SR61)

Operational Update

Positive operational updates in Gabon regarding the ongoing drilling program. Excellent initial flow rate of approximately 4,850 gross barrels of oil per day, 2,850 net to Vaalco.

ACG Metals (LON:ACG) (£375m | SR48)

Q1 2026 Operations and Capital Structure Update

Total production of 12,168 oz AuEq in Q1 2026, down 22% year-on-year, as expected. C1 cash costs down 12%. AISC rose 49% due to higher royalties on higher gold and silver prices. It was “a strong start to the year for ACG”.

Avacta (LON:AVCT) (£351m | SR31)

Avacta data AACR underline AVA6103 profile

Giving two presentations today at the American Association for Cancer Research Annual Meeting 2026. “The data being presented at AACR underline the potential of our pre|CISION® technology and AVA6103 to make a considerable difference to cancer patients.”

Nichols (LON:NICL) (£339m | SR73)

AGM Trading Update

Q1 revenue +4.3%, in line with expectations. Net cash £59.8m. FY26 revenue and adjusted PBT expectations are unchanged.

Capital (LON:CAPD) (£282m | SR99)

Q1 2026 Trading Update

Q1 revenue +41.6% year-on-year as a mining contract commenced (£18m vs. £0.6m last year). The drilling business performed “well” (revenue +8.8%). Full year revenue guidance is reiterated.AMBER/GREEN = (Roland)
Today’s trading update shows good progress in a number of areas, although my feeling from executive chair Jamie Boynton’s commentary is that the company’s investment portfolio is not doing as well this year, after reporting strong (mostly unrealised) gains last year. Broker forecasts are unchanged today, suggesting Capital is performing in line with expectations rather than ahead of them. The valuation still looks reasonable to me here and I think a broadly positive view remains fair.

Crest Nicholson Holdings (LON:CRST) (£278m | SR45)

Trading Update

Taking a more cautious view on sales, reducing volume expectations to 1,400 to 1,500 units (previously 1,550 to 1,700 units). Also anticipating a reduced number of land sales, with expected revenue of c. £40m (previously £75m to £100m). New EBIT guidance £5m to £15m, new net debt guidance of £100-120m.BLACK (RED ↓) (Roland)
Today’s update flags up a 79% reduction in EBIT guidance and a very large increase in year-end debt forecasts. The company is now in talks to relax its lending covenants and appears to be accelerating efforts to liquidate existing inventory. I think it’s prudent to take a negative view ahead of the company’s interim results, when we should get more clarity on the order pipeline and balance sheet situation.

S&U (LON:SUS) (£244m | SR96)

Preliminary Results

Profit before tax £31.8m (2025: £24.0m). Net assets £249m. “The current recovery shows we are on the right track, but challenges and necessary improvements remain - alongside real opportunities for growth.”GREEN = (Graham) [no section below]
I’m a broken record on this stock. Today' s results aren’t going to change my tune, with PBT bouncing back strongly and I think slightly beating expectations. PBT has been higher than this historically, and the overall size of the business is bigger than ever, so there is plenty of room for PBT to continue on this upward trajectory for the next few years - especially considering that the regulatory uncertainty and interventions have now ended. In the company’s words: “Advantage (the motor finance division) has seen a significant recovery following the regulatory, legal and fiscal onslaught of the previous two years.” The market cap is trading close to NAV, which is fair enough, but given the quality of the track record and management here I’m happy to remain positive. This is a family business which is managed to last for the long run.

Cab Payments Holdings (LON:CABP) (£230m | SR47)

Update on Q1 2026 income performance

Total income for Q1 2026 grew c.35%. “Excluding a non-repeating dislocation in Q4 2025, as previously highlighted, sequential QoQ performance was broadly flat and ahead of plan.” Medium term guidance unchanged.

Supreme (LON:SUP) (£178m | SR80)

New Licensing Agreement

Entered five-year licensing agreement with Carabao, an energy drink. Supreme will manufacture and distribute Carabao energy and isotonic drinks in the UK. Zeus upgrades FY26E adj EPS to 19.6p (prev. 18.0p) to reflect yesterday’s update. No change to FY27 estimates.

Accsys Technologies (LON:AXS) (£163m | SR43)

Trading Update

Revenue up 12% to €153m, with sales volumes +6% to 60,384m3. Expects FY26 adj EBITDA to be in line with consensus of €21m.

Activeops (LON:AOM) (£147m | SR38)

Full Year Trading Update and Notice of Results

Revenue to be up 48% to £45m, ahead of expectations. Adj EBITDA to be £4.2m, “marginally ahead” of expectations. Outlook: strong end to FY26 provides “a healthy position” for further progress in FY27.

MPAC (LON:MPAC) (£78m | SR26)

Full Year Results & Chief Financial Officer Succession

Revenue up 26%, adj pre-tax profit up 27% to £13.5m. Order book stabilised in H2 but was down 24% to £90m at the year end. Outlook: in line with expectations, with H2 weighting as in previous years. Current order book provides c.66% coverage of 2026 revenue. Some risk of disruption to client decisions due to the Middle East.

RED ↓ (Graham)
Normally, with a profit warning from a company we are neutral on, I’d take it down to AMBER/RED. However, in this case, there’s a fragile balance sheet and a reporting style that I haven’t found helpful. On top of that, a separate announcement today reveals that the CFO is leaving. He’s going to Ibstock (LON:IBST). The CFO jumping ship is a classic red flag. I’m therefore taking our view on this all the way down to RED

Likewise (LON:LIKE) (£58m | SR42)

Property and Trading Update & Notice of Results

Acquired freehold for a 2nd distribution centre in Leeds for £3m, using existing bank facilities. Q1 revenue up 15%, implying a significant increase in market share. Considering further growth investments.

Billington Holdings (LON:BILN) (£54m | SR95)

Results for the year ended 31 December 2025

Revenue down 15% to £96m, adjusted pre-tax profit down 62% to £4.1m. Dividend of 11p (2024: 25p). Expect improved 2026 result, in line with expectations.

Intercede (LON:IGP) (£53m | SR37)

New Contract Upsell Orders and Renewal

Further contract wins since 9 April include MyID CMS licence sales to UK and US government clients (total $3.7m) and a $0.1m renewal with a US Federal Agency. No change to Cavendish forecasts today.AMBER/RED = (Roland) [no section below]
Today’s market reaction seems a little over-egged to me, given that there are no changes to forecasts from Intercede’s house broker today. It’s also worth noting that the 9 April update referred to today wasn’t an upgrade either – the new orders and renewals reported were simply in line with expectations. Prior to that, forecasts were cut in March.
As far as I can see, this is another example of a small cap reporting business-as-usual contract wins in a rather promotional way. With the stock trading on a FY26E P/E of 20 after today’s gains, I am going to maintain our moderately negative view on this business until there’s more tangible evidence profits have returned to growth.

Gear4music (HOLDINGS) (LON:G4M) (£51m | SR89)

Trading Update

FY26 performance ahead of recently upgraded expectations. Sales up 30% to £191m. FY26 pre-tax profit to be not less than £9.7m (previous Singer forecast: £9.3m). FY27 outlook: trading to date is in line with expectations.GREEN = (Roland)
Today’s update is the seventh consecutive upgrade to FY26 guidance from this founder-led online retailer. While there’s no change to FY27 forecasts (profit is expected to fall as the cost base expands to support a new warehouse), I think the recent share price pullback discounts much of this risk.
I am also unwilling to bet against a business that appears to be executing well and has strong momentum. For these reasons, I’m leaving our positive view unchanged today.

System1 (LON:SYS1) (£38m | SR69)

Relationship Agreement with Brave Bison & Q4 and Full Year Trading Update

FY revenue steady at £37m, in line with previous guidance. Strong recovery in Platform revenue in H2. Adj EBITDA down 45% to £3.3m. FY27 outlook in line with market expectations.
Brave Bison can appoint a board observer, reflecting its status as 27.85% shareholder.
AMBER/GREEN = (Graham)

We are moderately positive on the stock, and I see no reason to change stance today. However, I can understand why long-term shareholders might feel dissatisfied. It’s been stop-start here for years, with the company’s evolution leading to higher revenues but no sustained increase in profitability. Despite the company’s emphasis on automated marketing tools, it has been a long wait for these efforts to scale profitably. Perhaps a takeover by a larger group is becoming the most logical outcome?

Everyman Media (LON:EMAN) (£31m | SR40)

Board Update and Notice of Results

Farah Golant CBE is appointed CEO with immediate effect, having been interim CEO since 1 January 2026. Results due on 28 April 2026.

Windar Photonics (LON:WPHO) (£30m | SR10)

CEO Appointment

Appoints Andreas Berg Nielsen as CEO, effective 1 June 2025. He is currently a NED and has previous experience in the wind energy and industrial B2B sector.

Checkit (LON:CKT) (£26m | SR41)

Final Results

Adj EBITDA up 113% to £0.3m, ahead of previous guidance for breakeven. ARR up 1% to £14.3m, with £4m cost saving programme completed. Formal sale process ongoing.
FY27: will retire a legacy product in order to free up resources needed to upgrade solutions. This “more than doubles our penetration potential”.

Abingdon Health (LON:ABDX) (£26m | SR24)

Admission to trading on OTCQB in the US

Trading will begin today on the OTCQB Venture Market in the US under the ticker ABDXF.

Genedrive (LON:GDR) (£16m | SR11)

NHS England commercial strategy for MT-RNR1

NHS England has published a market engagement notice relating to the procurement strategy for rapid genetic MT-RNR1 testing in neonates to prevent antibiotic induced hearing loss. Genedrive’s products are already in use in some trusts and management believes it’s well positioned to compete for the tender.

Ebiquity (LON:EBQ) (£16m | SR21)

Final Results

Revenue down 4%, adj pre-tax profit down 82% to £1.1m. Good performance in UK & Ireland offset by “challenges in North America and Europe”. Q1 began “encouragingly”, expects Q2 to provide “greater visibility on the full year outturn”.

IXICO (LON:IXI) (£16m | SR19)

Trading Update

H1 revenue to be up 23%, with gross margin to be 53% (H1 25: 50%). Order book of £18.1m, +38% vs 31 March 25. Trading in line with FY expectations.

Facilities by ADF (LON:ADF) (£12m | SR35)

Final results for the year ended 31 December 2025

Revenue up 17%, adjusted EBITDA up 28% to £9.2m driven by acquisitions. Q1 2026 trading in line with expectations, FY26 to show similar H2 weighting to FY25, reflecting current production patterns.

Graham's Section

Jupiter Fund Management (LON:JUP)

Up 3% at 156.8p (£828m) - Trading Update and Notice of Results - Graham - GREEN =

I’ve stayed positive on this one for momentum reasons (see here) with the original value thesis having already played out::

16a0a4dc-1a1c-4d61-aee0-14a5d3386b15.png

The positive momentum continues in the business.

Highlights from today’s update:

  • AUM up £14.4bn in the quarter, to £68.4bn

  • £15bn of additional AUM came in as the acquisition of CCLA completed

  • Positive net inflows of £1.5bn, including small net inflows during the turmoil in March (excluding CCLA).

CCLA itself saw small outflows during the quarter, and market movements were negative.

As a reminder, Jupiter has paid £100m for CCLA: a very cheap deal to my eyes, receiving £150 of AUM for every £1 they spent buying it.

That’s about half of the price of Jupiter shares currently (you’d get £83 of AUM for every £1 spent on Jupiter shares today).

A quick note on market sentiment:

Market sentiment has clearly shifted materially in recent weeks in response to geopolitical events. It is too early to tell if this represents a sustained change in client appetite towards risk assets or whether it will be more short-term and transitory. Despite the external environment, Jupiter remains in a stronger position today than we have been for a number of years and, with a broader, more diversified set of investment capabilities, are well-placed to take advantage of the opportunities that lie ahead.

Graham’s view

I respect the momentum at work here, and will stay positive. There are a few fund management businesses on my GREEN list - and Jupiter is one of them.

Ever since Matthew Beesley was hired as CEO in 2022, I thought his plans were remarkably logical - primarily around cost control and simplification in a tough environment.

Patient shareholders have been rewarded with positive net inflows, a cheap acquisition significantly boosting AUM, and a recovery in the share price.

The StockRank is 95 and my view is consistent with what the algorithms are saying here:

1e00c8f6-1b7b-4fa6-9f48-1e74fcbd97c8.png


MPAC (LON:MPAC)

Down 10% at 234p (£70m) - Graham - Full Year Results and CFO Succession - Graham - RED ↓

Mpac Group plc, the global packaging and automation solutions Group, today announces its results for the 12 months to 31 December 2025 ("FY25").

We’ve been neutral on this one (see here), and our lack of excitement seems justified given the reaction to today’s results.

Today’s financial highlights don’t look too bad at first glance, but the order book has fallen 24% year-on-year, and the statutory result - i.e. the result without any adjustments - is poor.

Those two facts are highlighted in red below:

52b68f9b-ed7d-4d71-a8cc-3bfeab6113c2.png

The list of adjustments (adding up to £21m) includes the usual categories, plus a few others.

A “customer dispute” cost £1.9m. “Reorganisation and site closures costs” were £3.4m.

If we want to ignore amortisation (£6m) and impairment (£8.4m), that’s fair enough, but in that case let’s not assume that the company’s intangible assets are worth anything.

If the intangibles are worthless, the balance sheet is left with net tangible assets of minus £33m, implying zero support for the share price coming from the balance sheet.

The net debt figure is £47.9m, which is now not all that far away from the company’s market cap (a signal I look out for).

Outlook

This isn’t terrible, but it is cautious, and sounds like the precursor to a downgrade:

The Group remains in line with full year market expectations, which as in previous years will be second half weighted, but, in the context of increasingly uncertain market conditions, it is difficult to predict the full impact of the Middle East conflict on the timing of customer capital investment decisions.

The combination of an H2 weighing and limited visibility implies a very high risk of a profit warning.

On the bright side, the company says that the order book stabilised in H2.

Estimates at ShoreCap are unchanged. Adj. PBT of £15.1m this year, then rising to £17.6m in 2027.

Graham’s view

What really irks me about these results is that the company doesn’t tell us plainly what the organic growth rates were.

For example, one of the acquired companies (CSi Palletising) generated €71.5m of revenues in 2023. That takeover completed in November 2024. So a comparison of 2025 vs. 2024 revenues for Mpac as a whole isn’t meaningful. Organic growth rates should be spelled out clearly.

Conclusion - normally, with a profit warning from a company we are neutral on, I’d take it down to AMBER/RED.

However, in this case, there’s a fragile balance sheet and a reporting style that I haven’t found helpful.

On top of that, a separate announcement today reveals that the CFO is leaving. He’s going to Ibstock (LON:IBST). The CFO jumping ship is a classic red flag.

I’m therefore taking our view on this all the way down to RED.

e27f3a0d-6b5c-4508-9908-f6e8c59e3f13.png

It might offer value at the current level - there is every chance I’ll take our view back to neutral in a few months. It could be worth investigating further. But today’s data points would steer me away from taking a chance on it for the time being.


System1 (LON:SYS1)

Down 2% at 292.56p (£37m) - Q4 & Full Year Trading Update - Graham - AMBER/GREEN =

Let’s check out the latest from this “marketing decision-making platform”:

  • Full-year revenue “steady” at £37m (prior year: £37.4m)

  • H2 was up 4% year-on-year

  • Adjusted PBT £2.1m (prior year: £5.2m), “in line with previous guidance”.

The year-end cash position £12.4m, and operating expenses are reduced by £1m per annum.

Outlook:

The strong level of new business wins secured throughout FY26 and particularly in the final quarter, provide confidence in delivering revenue and profit growth in FY27, in line with consensus market expectations.

Estimates from Singer, published earlier this month, suggest that adj. PBT can nearly double to £3.9m in FY27, with high operational gearing on increased revenues. Although that result still wouldn’t match what the company achieved previously.

CEO comment:

FY26 has seen the successful delivery on our plans to grow in the USA, revitalise our Innovation product offering and increase the number of the world's largest brands as customers. This progress against a challenging macro-economic environment delivered a resilient FY26 performance, a record H2 performance and places the business on an upwards trajectory into FY27.

Graham’s view

It’s been stop-start here for years, with the company’s evolution leading to higher revenues but no sustained increase in profitability.

We are moderately positive on the stock, and I see no reason to change stance today.

However, I can understand why long-term shareholders might feel dissatisfied.

Despite the company’s emphasis on automated marketing tools, it has been a long wait for these efforts to scale profitably.

3be0129f-1f46-4d7b-8b85-5c3c5123f25a.png

Is there a larger marketing group that would make a more profitable home for the company’s technologies?

Brave Bison (LON:BBSN) are now the largest shareholder. If not them, then perhaps someone else might start digging around here for a complete takeover? The healthy cash position would help to fund any deal.

Here’s an example of the multiples involved: the adjusted EBITDA forecast for the current year is nearly £5m, while the enterprise value is only £25m. So EV/EBITDA is 5x. That’s the sort of multiple that makes takeovers happen.

As a standalone investment, however, I think we need more proof that the business is scaling on its own, before we get too enthusiastic.


Roland's Section

Crest Nicholson Holdings (LON:CRST)

Down 39% at 65.8p (£169m) - Title - Roland - BLACK (RED ↓)

Commiserations to shareholders here this morning – this is a big profit warning.

ba41023f-74bb-442f-a2bd-0c3391d92a8c.png

I estimate that this troubled housebuilder has cut 2026 profit forecasts by more than 75% today, while increasing its debt guidance. That’s not a good combination!

Management blames macro uncertainty:

Since the Group's AGM trading update on 25 March, macro-uncertainty has increased, with the ongoing conflict in the Middle East contributing to the prospect of a more prolonged higher interest rate environment, renewed cost pressures and a deterioration in consumer confidence.

Market conditions for housebuilders are certainly difficult, as I’ve discussed in these pages a number of times recently. However, I’m pretty sure that some of Crest’s issues are internal. As Graham noted in November, this business appears somewhat accident prone. Earnings forecasts have already seen multiple downgrades over the last 18 months:

652f565c-171f-4275-9b0b-6b4690e4f236.png

Here are is the from today’s update, which covers the current financial year (since 1 Nov 25):

  • Home Sales: “Open market reservations have continued in line with the improved levels seen since mid-January.” Trading is positive in the Midlands, South-West and Eastern divisions, but softer in the South. Use of incentives and discounting has remained stable, but new enquiries have fallen.

  • Land Sales: Crest has completed one sale so far this year, but the market has softened and buyers are increasingly “reluctant to transact at market values”.

Outlook & Revised Guidance

As a result of softer market conditions, the company has now cut its guidance for both new home sales and land sales in FY26 (y/e 31 Oct):

  • Home sales: expected completions: 1,400 to 1,500 units (previously 1,550 to 1,700)

  • Current order book: 1,106

  • Land sales: now expected to total c.£40m (previously £70-100m). Management no longer expects to make any meaningful profit on land sales this year.

Unfortunately this operational slowdown means that profits are expected to be c.79% lower than previously expected, while borrowing levels are expected to be much higher:

  • FY26 EBIT (operating profit): now expected to be “around £5m to £15m” (my estimate: previously c.£47m)

  • FY26 interest costs: c.£15m (previously £10m to £12m)

  • Year-end net debt: £100 to £120m (previously £15m to £65m)

(The company’s previous guidance in January listed interest costs and pre-tax profit (not EBIT), so to get a comparable figure for today’s EBIT guidance I have simply added the mid-points of previous PBT and interest cost guidance.)

Unsurprisingly, the company is now stepping up efforts to sell off its completed inventory, while tightening control on spending on current developments. In a soft market, I would speculate that this is likely to require additional discounting or incentives, adding pressure to margins.

Higher energy costs are also expected to result in higher build costs this year.

Balance sheet worries? This situation has added pressure to Crest Nicholson’s balance sheet. This was already looking a little tight in our view – the previous two sets of accounts have both included going concern warnings on interest cover.

Today we learn the company is in talks to relax its lending covenants. There’s no suggestion Crest Nicholson is likely to become financially distressed, but the fact it’s under discussion is a risk from an equity perspective.

Roland’s view

Last year’s decision to pivot to become a “leading player in the mid-premium housing market” does not seem to be delivering the hoped-for results.

I wonder if performance would have been better if the company had redoubled its focus on bulk and affordable housing. These categories accounted for 35% of units sold last year, but the intention was to phase these out starting in FY26 and there was no mention of either category in today’s update.

While it’s true that market conditions are difficult, I think the real issue here for equity investors is the level of debt in the business.

Many of Crest’s peers have gone into this slowdown with strong net cash positions. This is allowing them to maintain optionality over land purchases and development timings. It also means they aren’t under pressure from lenders to liquidate their inventories and generate cash – something I suspect Crest is now experiencing.

This morning’s share price drop has left Crest shares trading at a 75% discount to its last-reported net asset value of 279p per share.

While such a large discount may seem tempting, I am inclined to view it as a warning flag for equity investors, for two reasons:

  • The combination of lower sales and a higher net debt position this year is likely to mean that Crest’s book value falls when its interim results are published;

  • There could be a growing risk that the company will need an equity raise to reduce debt and allow it to trade its way out of the current slowdown.

Graham downgraded our view to AMBER/RED in November, based on our disciplined approach to balance sheet risk.

I am going to move down another notch to RED today ahead of the interim results. I would not consider investing here until there’s some evidence the company can trade its way out of this dip without needing refinancing.


Gear4music (HOLDINGS) (LON:G4M)

Up 13% at 274p (£57.5m) - Trading Update - Roland - GREEN =

Musical equipment retailer Gear4Music has upgraded its profit guidance in each of its last seven trading updates, starting in June 2025.

The catch is that each of these upgrades has related to the FY26 financial year, which ended on 31 March. Brokers have been much more sparing in upgrading FY27 forecasts, with the result that profits are now expected to fall this year. Today’s update also leaves FY27 guidance unchanged:

01aabd3c-0e20-46ac-a966-a23ce571fbc4.png

What investors need to decide is whether the momentum displayed over the 12 months is likely to persist, potentially leading to FY27 upgrades.

Recent share price action suggests mixed views in the market (and perhaps some profit taking after a 100% gain in 12 months):

c13f6c88-026c-4e96-ad67-e193dc30365b.png

Let’s start with a closer look at today’s update.

Year-end trading update (y/e 31 Mar 26)

Gear4Music has clearly put in a stonking performance over the last year. Today’s guidance is ahead of forecasts, with pre-tax profit 4% higher than previous consensus:

  • Revenue up 30% to £190.7m, with UK +26% and Europe/ROW +36%;

  • Gross margin up 1.4% to 28.4%

  • Adjusted EBITDA to be up by “not less than” 81% to at least £18.1m

  • Pre-tax profit not less than £9.7m (FY25: £1.6m)

  • Net debt reduced to £5m (FY25: £6.4m), after £3.6m pre-payment on new warehouse

Previous consensus was for revenue of £186.4m and pre-tax profit of £9.3m, according to the company.

The company gives a shout out to new technical tools that have launched recently and are said to be supporting growth. The impact of such initiatives is sometimes hard to measure, but I think it’s good to see the company continuing to invest in efficiency and digital marketing:

  • AI based inventory forecasting and purchasing platform

  • Digital promotions centre

  • Website AI chatbot

Management commentary: Executive Chairman and founder Andrew Wass is certainly motivated to build a sustainable recovery. The value of his shareholding has risen from £6.5m to more than £12m over the last 12 months.

Today, he strikes a fairly positive note about the outlook for the current year (my bold):

Whilst it remains early in the financial year and the Board has not yet made any changes to FY27 forecasts, it remains confident that the business will build on the substantial financial progress achieved in FY26. Trading in FY27 to date is in line with consensus market expectations.

FY27 outlook

The company says FY27 trading so far is in line with consensus expectations. Gear4Music helpfully includes its view of consensus within today’s update:

  • FY27E revenue: £200.2m

  • FY27E adj EBITDA: £16.0m

  • FY27E adj pre-tax profit: £6.0m

  • FY27E adj EPS: 33.0p (courtesy of Progressive Research, previously 31.6p)

These estimates are, respectively, 5% ahead, 11% below and 62% below today’s FY26 guidance.

The large fall in forecast pre-tax profit reflects two factors:

  • An increase in the company’s operating cost base as its new warehouse becomes operational and higher wage and energy costs are annualised;

  • A reduction in expected gross margin in FY27.

A new note from Progressive Research today – many thanks – gives us the following detail on these margin pressures:

  • FY27E operating costs are expected to rise by 10% to £39.7m;

  • FY27E gross margin is expected to fall by 0.6% to 27.8%.

Higher revenue is expected to cancel out the lower gross margin, resulting in a modest increase in gross profit.

But a much larger increase in revenue would be needed to offset the increase in operating costs, hence the expected fall in pre-tax profit this year.

Roland’s view

Graham upgraded Gear4Music to GREEN in January, noting the terrific series of upgrades to EPS forecasts; today’s updated Progressive FY26E estimate of 33p is more than three times the 9p consensus estimate from April 2025.

While I have some slight nervousness about FY27, I think the recent pullback in the share price means that much of the expected reduction in earnings this year is already priced in.

Gear4Music’s current valuation doesn’t seem unreasonable to me:

ad09d57d-0ad4-42fc-86e9-bc6355598991.png

To my mind, today’s commentary leaves room for upgrades to FY27 forecasts if current trading conditions remain stable.

I’m going to leave our positive view unchanged today out of respect for the impressive momentum in this business currently.


Capital (LON:CAPD)

Up 5.5% at 132p (£294m) - Q1 2026 Trading Update - Roland - AMBER/GREEN =

Investors who bought back into gold mining services specialist Capital when co-founder Jamie Boynton took control again in March 2025 have been well rewarded. The stock’s discount to book value has been erased and the share price has doubled.

d0e3b336-213e-4a12-b501-c70fa7d33032.png

Of course, this recovery may not just reflect Boynton’s leadership – this period has also corresponded with a remarkable period for the gold price:

c4befa52-f500-4b4b-970f-7e613b051e52.png

When I last looked at Capital in October 2025, I upgraded our view to AMBER/GREEN, noting recent earnings upgrades.

Today’s update leaves 2026 guidance unchanged but does strike a fairly positive note:

  • Q1 revenue of $101.7m (+41.6% vs Q1 25 and +9.7% vs Q4 25);

  • Drilling and associated revenue up 4.3% to $62.8m vs Q4 25;

  • Mining revenue up 65.1% to $18m vs Q4 25;

  • MSALABS revenue down 3.2% to $20.9m vs Q4 25

  • Trading in line with 2026 revenue guidance of $410m to $440m;

Operationally, Capital reports solid progress during the quarter, albeit with a reduction in fleet utilisation:

  • Total fleet utilisation 70% (Q4 25: 74%)

  • Average monthly revenue per operating rig (ARPOR): up 7.5% to $201k vs Q4 25

  • Reko Diq mining contract is underway, with both fleets now being double shifted;

  • Re-commenced waste mining at Sukari under new contract;

  • MSALABS laboratory utilisation increased to 53% (Q1 25: 40%);

  • Newfoundland lab has started receiving samples, two further laboratories are under construction.

There are various new contract wins, including:

  • A 5-year deep hole mining contract at Sukari, in Egypt;

  • A 3-year drilling contract at the Kiniero Gold Project in Guyana.

Trading commentary: the company says it has not been directly affected by events in the Middle East, but has seen some impact on personnel and logistics. Capital’s investment portfolio (mostly gold miners) has also been hit “by a general slide in global equity markets”.

Full run rates are expected on Capital’s two mining contracts later this year, supporting revenue guidance.

Management also notes “strong tendering activity”, with good demand driven by record commodity prices and capital markets activity – in other words, gold is still booming.

Outlook - with thanks to Panmure Liberum, I can see that forecasts are unchanged today:

  • FY26E adj EPS: $0.15

  • FY27E adj EPS: $0.20

These estimates put Capital shares on a forward P/E of around 11, which seems fair to me.

Forecasts have been broadly stable for the last six months or so, suggesting the growth reported today is largely priced into existing forecasts:

0ecd60d8-55c5-4393-b4b0-32acf1565f50.png

Roland’s view

Capital’s reported profits can be skewed by unrealised movements in the value of its investment portfolio. This is one of the more unusual parts of this business – in addition to being a mining and drilling contractor, the company also invests in mining equity.

Presumably the company’s industry insight and connections leave it better positioned than most of us to invest profitably.

Last year Capital reported $66m of realised and unrealised investment gains (2024: $12m), but the cash flow statement only showed $4.7m of cash inflows from the sale of investments. If I’ve read this correctly, this meant the company was staying invested in the hope of further gains.

Today’s commentary from Boynton referring to a “general slide” in equity markets leaves me wondering if some of last year’s unrealised gains have now evaporated. If so, I’m a little surprised – my impression is that gold equity prices have remained pretty strong this year.

Time will tell. In the meantime, Capital’s improving operational performance and unchanged guidance mean I’m happy to leave our previous AMBER/GREEN view unchanged today.

Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

53 comments


Avatar for GavSmith01

Anyone else missing the old “down vote” button these last two days? :-/

3
Avatar for Subparstockpicks

Thanks all for getting this report - lots of companies to cover. No worries if there's not sufficient but could you please have a look at £Billington Holdings (LON:BILN) on the weekend?

2
Avatar for ken mitchell

Crest Nicholson Holdings (LON:CRST) is yet another example of it being best to sell on a profits warning. Crest Nicholson Holdings (LON:CRST)issued a profits warning last November. The share could have been sold after that warning at double the price it ended up at today after their latest dire update.

Also there are so many better quality housebuilders to invest in if keen on the sector. e.g Persimmon (LON:PSN) and Barratt Redrow(LON:BTRW).

18
Avatar for Wimbledonsprinter

On Capital (LON:CAPD, I think the big issue in 2027 is what happens at Reko Diq.    Capital are still expecting a ramp up at both its mining contracts (Reko Diq and Sukari, with Reko Diq being the most important).    On 2 April, Barrick issued a press release stating that given the security situation in Baluchistan, the Reko Diq review was going to be extended into mid-2027.  "The continued review will allow [Barrick] to assess in a comprehensive manner the evolving security situation, capital requirements, project financing, project scope and timeline."    Capital will have a lot better insight into spending upto mid-2027 but there must be considerable doubt about what the long-term outlook is for Capital at Reko Diq in the longer-term.

7
Avatar for Thatmanrobert

For LSE:JUP (Jupiter Fund Management plc), the analysis as of April 21, 2026, indicates a stock in a Stage 1 "Repair" Phase attempting to stabilize after a volatile ex-dividend adjustment. While the stock has faced downward pressure throughout April, it is currently testing critical support at its 200-day moving average. The recent launch of a fresh buyback program and the first year of positive net inflows since 2017 suggest a fundamental turning point is underway.

Technical Analysis: The 1-Day Chart (Last 10 Trading Days)

Jupiter's price action in April has been dominated by its ex-dividend date on April 16. The stock saw significant distribution leading into the date but has since begun a "V-shaped" attempt to reclaim the 155p-160p range.

Date (2026)

Price (GBX)

% Change

Volume Signal

Apr 08

166.0

+0.36%

£30m Buyback Announced

Apr 09

158.0

-4.82%

Institutional Churn

Apr 10

157.6

-0.25%

Constructive Tightening

Apr 13

159.0

+0.89%

Low-volume Absorption

Apr 14

162.4

+2.14%

Pre-dividend Accumulation

Apr 15

161.6

-0.49%

High-level Churn

Apr 16

152.4

-5.69%

Ex-Dividend Date Adjustment

Apr 17

154.2

+1.18%

Pivot Bottom Attempt

Apr 20

152.8

-0.91%

Test of 200-day SMA

Apr 21

157.4

+3.01%

Power Rebound (Buyback Support)

The 10 Best Indicators & Signals

  1. 200-Day SMA (~153.1p): Bullish Support. Price is currently bouncing off the 200-day line, a key Stage 1 floor.
  2. 50-Day SMA (~177.0p): Bearish. Price remains ~11% below the 50-day; a Stage 2 transition requires a reclaim of 172p.
  3. Relative Strength (RS) Rating: 63. Average. Underperforming the broader financials sector in April but showing 1-week resilience.
  4. Volume (Accumulation): Bullish. Up-days (Apr 14, 21) are showing 1.2x higher volume than non-dividend down-days.
  5. RSI (14): 38.5. Oversold Recovery. Climbing out of the 30-zone; suggests the selling is exhausted.
  6. MACD (12, 26, 9): Bullish Crossover. A fresh signal was issued on April 16, hinting at a momentum shift.
  7. Bollinger Bands: Lower Band Support. Price touched the lower band at 151p and is now reverting to the mean.
  8. On-Balance Volume (OBV): Flattening. Selling pressure has leveled off, suggesting "Strong Hands" are holding through the dividend.
  9. Stochastic (9,6): 42. Improving. Recovering from deep oversold territory.
  10. Buyback Signal: Vertical. The active £30m share buyback launched April 8 provides a persistent structural bid.

Weiss Wave Strength: Improving (6.8/10)

The Weiss Wave shows that "Up Wave" volume since the April 16th ex-div drop is 2.2x larger than the average selling waves. This indicates that value-oriented institutions and the corporate buyback are effectively "cleaning up" the supply left by dividend-capture traders.

Fundamental Review

  • Inflow Turnaround: For the first time since 2017, Jupiter reported positive net inflows (£1.3bn) for the full year 2025. This is a major psychological hurdle cleared for the "recovery" narrative.
  • AUM Growth: Total Assets Under Management (AUM) reached £54.0bn, up 19% YoY, bolstered by the CCLA acquisition and positive market performance.
  • Profitability: Underlying profit before tax jumped 42% to £138.3m, driven by a significant surge in performance fees (£120.3m).
  • Capital Returns: Management hiked the total payout by 87% to 10.1p for the year. The latest final dividend (2.3p) and special dividend (~5.8p equivalent) were detached on April 16.
  • Valuation: Trading at a forward P/E of ~8.8x, Jupiter remains one of the cheapest mid-cap asset managers on the LSE, particularly given its high cash-flow generation.

Conclusion: Buy/Sell Recommendation

Verdict: BUY (Stage 1 Bottoming Play)

Jupiter is currently a "Value-to-Momentum" transition play. The technical damage caused by the April ex-dividend drop has created a low-risk entry point near the 200-day moving average.

  • Trade Logic: The stock has successfully "undercut and recovered" its 152p support level. With the £30m buyback active and the sector seeing improved sentiment, the path of least resistance is back toward the 50-day SMA.
  • Entry: Buy at current levels (157.4p).
  • Stop-Loss: Hard stop at 148.0p (below the recent pivot low and Bollinger floor).
  • Target: Initial technical target is the 172p resistance zone. Long-term target is 195p as net inflows continue to accelerate in H2 2026.

Recommendation: BUY. Jupiter is being de-risked by its own buyback program. This is a classic "Strong Hands" accumulation zone before the next Stage leg up.


14
Avatar for Lord Gnome

Excuse my ignorance, but where is all this technical analysis coming from?

9
Avatar for Thatmanrobert

ChartMasters, and available until  the end of May.The analysis lets you feel the market pulse of the share with a technical weighting  not found elsewhere while paving entry with clear guardrails which define  the risk reward ratio  apart from being educational  for anyone wanting a better understanding/appreciation of charts

5
Avatar for Lord Gnome

Thank you. Do you have a link that you could share, please? I've tried searching for them and just get sites related to pop charts!

2
Avatar for Jon F
2
Avatar for Thatmanrobert

ChartMasters Intelligence 

1
Avatar for Thatmanrobert

For LSE:SAGA (Saga plc), the analysis as of April 21, 2026, indicates a powerful Stage 2 Breakout and a "Structural Re-rating" event. Following the transformational FY2026 results released on April 15, the stock has decoupled from its long-term downtrend and is now exhibiting the "superperformance" characteristics prized by Dan Zanger and Michael O'Neil, including high-volume gaps and vertical relative strength.

Technical Analysis: The 1-Day Chart (Last 10 Trading Days)

Saga has undergone a massive "Institutional Pivot" over the last fortnight. The +30% surge from the April 7th lows was capped by a "Power Gap" on April 15th, followed by a constructive high-level consolidation that suggests a secondary base is already forming.

Date (2026)

Price (GBX)

% Change

Volume Signal

Apr 07

468.0

-3.81%

Final Shakeout / Support Test

Apr 08

530.0

+13.25%

Accumulation (Institutional Buy)

Apr 09

533.0

+0.57%

Constructive Churn

Apr 10

551.0

+3.38%

Demand Expansion

Apr 13

569.0

+3.27%

Pocket Pivot (Reclaiming SMAs)

Apr 14

582.0

+2.28%

Pre-earnings Tightness

Apr 15

617.0

+6.01%

Earnings Gap (2.27M Vol)

Apr 16

622.0

+0.81%

High-level Absorption

Apr 17

620.0

-0.32%

Natural Reaction (Low Vol)

Apr 21

635.6

+2.52%

Power Breakout (Intraday High)

The 10 Best Indicators & Signals

  1. 200-Day SMA (~331.0p): Strong Bullish. Price is ~92% above the 200-day, satisfying the primary Stage 2 Trend Template.
  2. 50-Day SMA (~595.2p): Bullish. The stock gapped above the 50-day on April 15 and is now using it as an "escape velocity" floor.
  3. Relative Strength (RS) Rating: 98. Elite. Outperforming 98% of the LSE; hitting a new 52-week relative high against the FTSE 250.
  4. Volume (Accumulation): Strong Buy. The 2.27M spike on earnings day is the largest in 12 months, indicating a major fund "buy-in."
  5. RSI (14): 63.1. Momentum Zone. Pulling back slightly from "overbought," allowing for a low-cheat entry before a secondary run.
  6. MACD (12, 26, 9): Bullish Vertical. The signal line was cleared with extreme force, suggesting a multi-month trend shift.
  7. Bollinger Bands: Upper Band Extension. Price is "walking the bands," a sign of institutional urgency.
  8. On-Balance Volume (OBV): Rising Vertical. Confirmation that volume is supporting the price advance into "Blue Sky" territory.
  9. Stochastic (9,6): 84.0. Strength. Recovering from a mid-month pause; currently pinning to the top of the range.
  10. ATR (14): 9.3p. Stable-High. Reflects healthy volatility suitable for a high-growth momentum vehicle.

Weiss Wave Strength: Dominant (9.4/10)

The Weiss Wave shows a "Tsunami" of buying. Cumulative volume on the "Up Waves" since the April 8th reversal is 4.2x larger than any selling volume seen in Q1. This indicates that the "Weak Hands" have been flushed and the float is now tightly held by long-term growth funds.

Fundamental Review

  • Earnings Breakout: FY2026 results (ended Jan 31) showed underlying profit before tax up 19% to £44.2m, surpassing guidance. Revenue rose 11% to £654.6m.
  • Debt Reduction: Net debt was slashed by £93.3m to £499.5m. The leverage ratio improved to 3.7x (from 4.4x), heading toward a medium-term target of <2.0x.
  • The Ageas Partnership: The insurance partnership with Ageas has successfully "de-risked" the insurance broking model, allowing Saga to focus on its high-margin travel business.
  • Ocean Cruise Dominance: The travel segment is the primary engine, with a 37% surge in travel profit (£87.2m). Per diem pricing for 2027 is already up 13% (£447), showing immense pricing power.
  • Valuation: Despite the run, the stock trades at a forward P/E of ~12.5x–14x (normalized), which remains attractive relative to its historical recovery multiple of 18x.

Conclusion: Buy/Sell Recommendation

Verdict: BUY (Stage 2 Breakout)

Saga has successfully completed its "Repair Phase" and is now in a Stage 2 Discovery Phase. The combination of record cruise per diems, debt reduction, and the insurance pivot has created a "Superperformer" technical setup.

  • Trade Logic: The stock has cleared its 52-week high of 652p recently and is currently in a "Buyable Pullback" zone following the earnings gap. The high-volume "Institutional Footprint" is unmistakable.
  • Entry: Buy at current levels (635p) or on a close above the 653p resistance.
  • Stop-Loss: Hard stop at 590p (just below the 50-day SMA and the April 15th gap floor).
  • Target: Initial technical target is 750p. Long-term "Recovery" target is 850p as leverage falls below 3.0x.

Recommendation: BUY. Saga is currently the strongest "Special Situations" turnaround on the LSE. As Michael O'Neil would suggest, "Buy the strength, not the bargain." The institutional "Tidal Wave" is in full motion.


17
Avatar for Thatmanrobert

Life goes on  through the passing clouds. Which shares are standing up to it?


1
Avatar for Revs8

I was surprised by the lack of volume and reaction to Jupiter Fund Management (LON:JUP) first thing. I was reassured by the update so added. Retest of support. 

02a642b6-6973-48ef-be90-147d01993371.png

3
Avatar for Thatmanrobert

Lovely cup and handle pattern  popularised  by O’Neil school showing a U-shaped cup ( not a V) followed by a slight downward drift forming the handle which provides a clear pivot point for entry.Its a classic continuation pattern until it’s not.It rewards patience  and more so when running over3/5 sessions.

7
Avatar for Thatmanrobert

Will retail go in for the dead cat bounce?

For LSE:CRST (Crest Nicholson Holdings plc), the analysis as of April 21, 2026, reveals a stock in a violent Stage 4 Capitulation. Following a catastrophic profit warning issued this morning, the stock has experienced a "Black Swan" gap-down, losing over 35% of its value in a single session. Following the Mark Minervini framework, this is a "Broken Stock" that has failed every technical support level and is now in a state of financial distress.

Technical Analysis: The 1-Day Chart (Last 10 Trading Days)

Crest Nicholson was attempting to build a Stage 1 base throughout early April, but today’s news has effectively "vaporized" the recovery thesis. The price action shows a massive gap-down on extreme institutional distribution volume.

Date (2026)

Price (GBX)

% Change

Volume Signal

Apr 07

118.2

-0.34%

High Court Ruling (Temporary Support)

Apr 08

119.5

+1.10%

Low-volume drift

Apr 09

117.8

-1.42%

Sector-wide weakness

Apr 10

117.2

-0.51%

Support at 117p

Apr 13

113.2

-3.41%

Institutional Selling Begins

Apr 14

114.5

+1.15%

Dead-cat bounce

Apr 15

113.8

-0.61%

Churn

Apr 16

115.2

+1.23%

Pre-warning "Trap"

Apr 17

115.2

0.00%

Neutral close before weekend

Apr 21

74.6

-35.19%

CAPITULATION GAP (Extreme Vol)

The 10 Best Indicators & Signals

  1. 200-Day SMA (~134.5p): Strong Bearish. Price is ~45% below the 200-day; a definitive Stage 4 disaster.
  2. 50-Day SMA (~112.8p): Strong Bearish. The stock gapped through the 50-day like it didn't exist.
  3. Relative Strength (RS) Rating: 04. Worst in Class. Outperforming only 4% of the market; the ultimate "laggard."
  4. Volume (Distribution): Extreme. Today's volume is currently 8x the 30-day average, indicating a total institutional exit.
  5. RSI (14): 18.2. Deeply Oversold. While statistically "cheap," in Stage 4, RSI can stay oversold for months as the company de-leverages.
  6. MACD (12, 26, 9): Histogram Collapse. A vertical move into negative territory, signaling a complete loss of momentum.
  7. Bollinger Bands: Band Breach. Price is currently trading well below the lower Bollinger Band, indicating an "extreme event."
  8. On-Balance Volume (OBV): Vertical Decline. Confirms that the move is driven by genuine capital flight.
  9. Stochastic (9,6): 05. Pinned. Showing no signs of a short-term bottom.
  10. Pattern: Gap-and-Go (Downside). A Dan Zanger "Avoid" setup. No "cheat" entry is possible here.

Weiss Wave Strength: Catastrophic (1.2/10)

The Weiss Wave indicates a "Selling Tsunami." The selling pressure today alone is larger than the cumulative buying volume of the entire first quarter of 2026. This is not a "shakeout"—it is a fundamental liquidation.

Fundamental Review

  • The Profit Warning (April 21, 2026): Management slashed 2026 EBIT guidance from a consensus of £43.7m down to just £5m–£15m.
  • Pre-Tax Loss Expected: Due to interest costs of ~£15m, Crest Nicholson now expects a pre-tax loss of up to £10m for the full year.
  • Banking Covenant Relief: The most alarming signal is that the company is currently seeking covenant relaxation from its lenders. This introduces significant "going concern" risk and prevents any immediate institutional re-entry.
  • Completions & Land Sales: Unit guidance was cut by 10% (1,400–1,500 units), and projected land sales were halved to £40m due to "reduced buyer engagement."
  • Legal "Silver Lining": The only positive is a recent High Court win in Crest Nicholson v Ardmore regarding fire safety defects, which may allow the company to recover some remediation costs. However, this is "too little, too late" for the 2026 P&L.

Conclusion: Buy/Sell Recommendation

Verdict: SELL / AVOID (Stage 4 Falling Knife)

Crest Nicholson is currently the "Sick Man" of the housebuilding sector. While peers like BDEV and VTY are attempting Stage 1 turnarounds, CRST has suffered a fundamental fracture.

Trader Note: Never "bottom fish" in a stock seeking covenant relief. The risk of a highly dilutive equity raise or a total wipeout is high.

  • Trade Logic: This is a classic Stage 4 gap-down. The stock has failed its 52-week lows and is now in "Blue Sky" territory to the downside (price discovery at decade lows). Institutional investors will wait for the banking covenant outcome before even considering a bid.
  • Entry: DO NOT ENTER. Do not try to catch the falling knife.
  • Stop-Loss: If trapped, a "stop-at-any-price" was triggered at the 110p mark. Any rally to the 90p level should be used as a liquidation opportunity.
  • Target: There is no technical floor until the 55p–60p range (2008-2009 historical lows adjusted for inflation).

Recommendation: AVOID. Reallocate all capital to Stage 2 sector leaders like LSE:SUP or LSE:RR. where the "Tidal Wave" is moving in your favor. CRST is a value trap that has just sprung.



18
Avatar for Claverton 2

Thank you so much Ed and Graham for the updates and such a swift resolution. 

Keep up the great work! 

15
Avatar for mikebianchi

Luckily my other major venture was hydrogen via an ETF HTWG this has a rocket under it, many related CERES, AFC and even CPH2 showing signs of life

1
Avatar for mikebianchi

Time for No11 to step up to the plate Osbourne style "We're going to get the housing sector moving" or much egg on the face house building target is laughable. I'm heavy on builders and bricks alas bad timing but then we dont have hindsight do we

6
Avatar for Shai Etanelov

Crest Nicholson Holdings (LON:CRST) tu and price not affecting other HB  

2
Avatar for The Boon Fund

I'm also surprised. Has the bad news been priced into other HBs already?

I hold Barratt Redrow (LON:BTRW) so read today's statement by Crest with some alarm. Lowering sales forecast for the rest of the year, despite being good so far. Higher build costs. Land bank now worth less than paid for.

Are the problems at Crest specific to it? Would love to hear from those who know more about the HB sector than me!

17
Avatar for Bouden54

It's well known that if build costs go up  while house prices flat or falling, that land costs will need to fall (sometimes qutie sharply) in order for housebuilders to maintain their margins. This is why I am cautious on valuing them with reference to book value. Not an expert on the sector and I understand builders may often use land options to help offset rising costs, but even so this I would be wary about those NAVs. The only one I hold is Persimmon as they seem to have the lowest costs and highest margins so should be best placed to overcome these headwinds. 

13
Avatar for The Boon Fund

I agree, need a good margin of discount to NAV to buy atm.

I was also digging into the "price" of land paid by all the big HBs in the last few years. 2022-2024 seems to be elevated prices, but 2025 sharply lower. Not easy to get a clean £/acre type calculation though, and also with mix across the country. So I'd value any qualitative views from those familiar with the sector whether there is a big chunk of overpaid land acquired in 2022-2024 sitting on books at the moment.

As the land gets used (2-5 year time horizon) it should mean that the land NAV is more solid.

7
Avatar for Rudy65

Land sale market has dried up atm with preference given to converting existing options into deliverable planning permissions. Plenty of land coming to the market in 2027 apparently. I definitely wouldn't be trusting current NAV's due to lack of sale comparables and negative sentiment. I hold TW and PSN

7
Avatar for Berksbee

I would be very interested in hearing your views on (LON:MPAC).  Off a fair bit this am and the Stocko ranks have nose dived of late - but there are some mixed messages in the  numbers - and unraveling them is above my pay grade!  Is it a hidden gem? £5m cash being returned from pension fund etc. 

7
Avatar for TheRaven

As I buy my jeans and t shirts from Primark, I'm a fan. I'll be interested to see what effect the demerger has on the overall share price, and how the share price splits between the two new companies.

6
Avatar for Edward Croft

Sorry about the site issues this morning.  Our team have been on this, and getting to the bottom of it.  

While I don't have a clear diagnosis quite yet, we have had a few issues recently with some users who are scraping the site.  So I wouldn't be surprised if this is the case this morning.  Unfortunately, these users are breaching our terms of use, and their activities impair the service levels for everyone else.    

Please be reassured we're on top of this and will be taking further action.  I'll circle back later. 

101
Avatar for Revs8

Thanks for the update Ed. The app is almost unusable for me this morning. I hope you can fix it in good time. 

2
Avatar for Silver Moon

Scraping the site?  Please tell more more about such an activity Ed.

13
Avatar for sharw

I didn't know what "scraping the site" was but all you need to do is highlight the words and right click search google and it will be clear.

3
Avatar for JimMcLad

It was a new term for me so I scraped this off Google.

“Web scraping (web harvesting or web data extraction) is a computer software technique that allows you to extract information from websites

Scraping and republishing such content without permission can constitute plagiarism or copyright infringement. Data Misuse: Data collected through scraping can be used for unethical or illegal purposes such as phishing, spamming, deepfake generation or identity theft.”

18
Avatar for TheRaven

Competitors robbing off Stocko? That's a back-handed compliment then. Hopefully the offending accounts will be quickly identified and sent hither.

14
Avatar for JSchoffer

Likely much less nefarious - a subscriber might scrape from Stockopedia to run their own reports. Can be just a way to get info from the website and display it differently, chances are they didn't realise they were doing any wrong!

4
Avatar for TheRaven

Fair enough; maybe now the people causing the issues are more aware, the problems will cease for the rest of Stocko's subscribers.

5
Avatar for ISAallowance

That's quite funny, given that Google have built a trillion dollar business based on scraping the entire web!

18
Avatar for sharw

Perhaps it was google causing the problem this morning! I asked it "what stock ranks does stockopedia give to gsk?" and got:

AI Overview 

Based on Stockopedia's analysis as of April 2026, GSK is classified as a High Flyer.

The company has recently achieved high composite scores, with recent mentions indicating a StockRank (SR) in the low 90s, such as SR94 and SR92. Stockopedia classifies GSK with the following characteristics:

  • Style: High Flyer
  • Quality Rank: 63 (above average, but not top-tier)
  • Momentum: Strong (outperforming the FTSE All Share Index by +17.24% over the past six months, trading high against its 200-day moving average)
  • Valuation: Considered a "Value" opportunity by some metrics, with a forward P/E frequently noted around 10–12

This classification indicates a combination of strong price momentum and solid fundamental characteristics, making it a high-ranking stock on the platform, often appearing as a strong contender in the pharmaceutical sector.

16
Avatar for Subparstockpicks

Hey Ed thanks for the update. You you ever considering making an API (Google sheets integration) for subscribers (limited to limited calls per day). Would definitely appreciate this as a user, and if it makes the site more stable then even better! 

3
Avatar for Subparstockpicks

* a certain number of API calls per day

0
Avatar for JASVFS

Good luck with tackling another long agenda Graham.  ABF and Billington are on our monitoring list. I think expecting a valuation for Primark in line with Next is an elasticated trouser stretch too far! We hold CAPD which seems to have justified the recent share price rally although it has fallen back a bit.

11
Avatar for gilesw

yea these capd results look fantastic, the stock got hit on the reko diq news and gold price fall but to my eyes this looks like a very strong business!

4
Avatar for bryaz

If it's any help I was getting 404 errors last night

8
Avatar for Rusty2

Yes, site unusable last night and today. Message saying some users may be finding the site is slow, is totally missing the point. Even typing this is difficult.

Can't access any Stockreports. 

2
Avatar for Marcus Pugh

I'm getting 404 errors this morning and also "no price available".  Stockopedia wasn't running smoothly yesterday also!

1
Avatar for dpanchal

Graham any thoughts on the results of System1 would be appreciated

2
Avatar for Graham Neary

Sincere apologies - we have a senior engineer investigating the issues.

39
Avatar for ezlifeme

Despite the site issues - I much appreciate your speed in populating todays Agenda Graham. My initial go to each day for quick reference

31
Avatar for TheRaven

Yes more 404 errors and pages not fully loading. Have reported on green button

5
Avatar for SCI20

Frustrating yes but not the end of the world. 

20
Avatar for Chas Robinson

I have been trying to use several features since 6am this morning. Search not working and no RNS updates. Not the first time this year. Maybe time to part ways

11
Avatar for Joeyredeye

Get over it. There’s  worse happening in the world. This is a minor inconvenience .It’s not like you can’t buy or sell…

22
Avatar for MB73

Come on ! Unacceptable 404 errors 

11
Avatar for SCI20

Another 404 morning. 

18
Avatar for Neil McQuillan

Agreed 404 trying to read RNS updates.

14
Avatar for TrickyRicky75

Very frustrating, I use this couple of hours before the markets open to sift through shares on my watchlist looking at news updates, charts etc.....

16
Get the free newsletter